1. Home
  2. EE vs SPTX Comparison

EE vs SPTX Comparison

Compare EE & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Excelerate Energy Inc.

EE

Excelerate Energy Inc.

N/A

Current Price

$32.13

Market Cap

1.2B

Sector

Utilities

ML Signal

N/A

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$18.95

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EE
SPTX
Founded
2003
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2022
2026

Fundamental Metrics

Financial Performance
Metric
EE
SPTX
Price
$32.13
$18.95
Analyst Decision
Buy
Strong Buy
Analyst Count
13
8
Target Price
★ $43.46
$38.29
AVG Volume (30 Days)
★ 387.7K
155.6K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
★ 1.12%
N/A
EPS Growth
★ 0.79
N/A
EPS
★ 0.75
N/A
Revenue
★ $1,228,263,000.00
N/A
Revenue This Year
$24.05
N/A
Revenue Next Year
$27.03
N/A
P/E Ratio
$43.27
★ N/A
Revenue Growth
★ 44.26
N/A
52 Week Low
$24.89
$17.59
52 Week High
$43.18
$28.38

Technical Indicators

Market Signals
Indicator
EE
SPTX
Relative Strength Index (RSI) 29.09 44.86
Support Level $32.03 $18.72
Resistance Level $36.04 $22.75
Average True Range (ATR) 1.34 1.81
MACD -0.44 -0.26
Stochastic Oscillator 7.59 32.71

Price Performance

Historical Comparison
EE
SPTX

About EE Excelerate Energy Inc.

Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: